IBD, the oral contraceptive pill and pregnancy
This chapter summarizes our current knowledge of the role of the oral contraceptive pill in the pathogenesis of inflammatory bowel disease (IBD), followed by a review of fertility in women and men. The next section considers IBD and pregnancy, including the impact on the fetus and the mother with ulcerative colitis or Crohn’s disease. The chapter then considers the safety of drug treatment and the outcome of surgical treatment during pregnancy and the problems that may be encountered during pregnancy in patients with an ileostomy or ileoanal pouch. The chapter closes with a review of the short- and long-term prognosis of ulcerative colitis and Crohn’s disease after parturition.
KeywordsInflammatory Bowel Disease Ulcerative Colitis Oral Contraceptive Pill Excess Relative Risk Oral Contraceptive User
Unable to display preview. Download preview PDF.
- 6.Willoughby CP. Fertility, pregnancy and inflammatory bowel disease. In: Allan RN, Keighley MRB, Hawkins CF, Alexander-Williams J, editors. Inflammatory bowel diseases, 2nd edn. Edinburgh: Churchill Livingstone; 1990: 547–58.Google Scholar
- 8.Willoughby CP. Fertility, pregnancy and inflammatory bowel disease. In: Allan RN, Keighley MRB, Hawkins CF, Alexander-Williams J, editors. Inflammatory bowel diseases, 2nd edn. Edinburgh: Churchill-Livingstone; 1990: 555.Google Scholar
- 10.Nielson OH, Andreasson B, Bondesen S, Jacobson O, Jarnum S. Pregnancy in Crohn’s disease. Scand J Gastroenterol. 1984; 19: 724–32.Google Scholar
- 12.Piper JM, Mitchell EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynaecol. 1993; 82: 348–52.Google Scholar
- 13.Davies PM. Azathioprine in pregnancy. Wellcome Foundation, personal communication.Google Scholar